1-1 of 1
Thorsten Braun, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I-II Study of Vorinostat and Low Dose Cytarabine for Patients Treated for High Risk Myelodysplastic with Azacytidine Failure: The GFM-VOR2007 Study

Thomas Prebet, M.D., Ph.D., Thorsten Braun, M.D., Ph.D., Odile Beyne Rauzy, Francois Dreyfus, Aspasia Stamatoullas, Eric Wattel, Shanti Ame, MD, Emmanuel Raffoux, MD, Jacques Delaunay, Celia Salanoubat, Isabelle Mathieu, Fatiha Chermat, Lionel Ades, Pierre Fenaux, MD, PhD, Norbert Vey, MD
Journal: Blood
Blood (2010) 116 (21): 4003.
https://doi.org/10.1182/blood.V116.21.4003.4003
Published: 2010